Emerging infectious diseases, 2007-04, Vol.13 (4), p.608-610
2007
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Endpoints for lymphatic filariasis programs
- Ist Teil von
- Emerging infectious diseases, 2007-04, Vol.13 (4), p.608-610
- Ort / Verlag
- United States: U.S. National Center for Infectious Diseases
- Erscheinungsjahr
- 2007
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1080-6040eISSN: 1080-6059DOI: 10.3201/eid1304.061063Titel-ID: cdi_doaj_primary_oai_doaj_org_article_618240c3dd1444f7ac4de3cd0291d038
- Format
- –
- Schlagworte
- Albendazole - administration & dosage, Albendazole - adverse effects, Albendazole - therapeutic use, Animals, diethylcarbamazine (DEC), Diethylcarbamazine - administration & dosage, Diethylcarbamazine - adverse effects, Diethylcarbamazine - therapeutic use, Disease transmission, Dispatch, Drug Therapy, Combination, Elephantiasis, Filarial - drug therapy, Elephantiasis, Filarial - epidemiology, Elephantiasis, Filarial - parasitology, Elephantiasis, Filarial - prevention & control, elimination, Filariasis, Filaricides - administration & dosage, Filaricides - adverse effects, Filaricides - therapeutic use, Government Programs - standards, Haiti - epidemiology, Health aspects, Humans, Infection, lymphatic filariasis, mass drug administration, microfilaremia, Microfilariae - drug effects, Mosquitoes, Prevalence, Program Evaluation, Wuchereria bancrofti, Wuchereria bancrofti - drug effects